MARPE and Orthognathic Plans:
Sequencing Logic
When Expansion Meets Skeletal Surgery
Master the clinical decision tree: expand first, or operate first? Learn when MARPE and orthognathic correction work together—and why timing matters.
TL;DR MARPE and orthognathic surgery require careful sequencing. Expand first in most cases to maximize skeletal response and simplify surgical vectors. Timing depends on midpalatal suture maturity, surgical complexity, and dentoalveolar space. Coordination between orthodontist and surgeon is essential for optimal outcomes.
When maxillary transverse deficiency coincides with skeletal discrepancies requiring orthognathic correction, the sequencing of MARPE and orthognathic surgery becomes a critical treatment decision. Dr. Mark Radzhabov and other evidence-based practitioners must determine: should miniscrew-assisted rapid palatal expansion precede jaw surgery, run concurrently, or follow surgical correction? This article examines the clinical logic, biomechanical principles, and practical protocols for coordinating MARPE with orthognathic plans—drawing on the latest evidence and real-world case workflows to help you avoid costly treatment delays and surgical complications.
What Is MARPE and Orthognathic
Coordination
and Why It Matters
Patients with both transverse maxillary deficiency and sagittal or vertical skeletal discrepancies present a complex treatment scenario. The presence of a narrow maxilla often coexists with Class II malocclusion, anterior open bite, or asymmetry—each requiring surgical correction. Traditionally, orthodontists relied on conventional RPE, which exerts dentoalveolar forces through tooth-anchored appliances, leading to significant buccal flare and requiring later decompensation. Miniscrew-assisted rapid palatal expansion (MARPE) offers skeletal loading directly to the palate, bypassing dental anchorages and producing more orthopedic (skeletal) response with less dentoalveolar side effect. When surgery is also planned, the question becomes: in what sequence should these two major interventions occur? A 2022 prospective randomized clinical trial comparing RPE and MARPE reported that MARPE achieved greater nasal width expansion and lesser buccal displacement of anchor teeth compared to conventional expansion. This evidence suggests that skeletal loading produces a cleaner bone response—one that simplifies the surgeon's task. However, the surgical plan itself may dictate timing. Large bimaxillary corrections, asymmetries, or Le Fort I osteotomies can be influenced by whether the maxilla is already expanded before the surgeon enters the case. The clinical logic of sequencing rests on several principles: (1) suture maturity and the capacity for orthopedic response, (2) the magnitude and type of surgical correction needed, (3) dentoalveolar alignment before surgery, and (4) the predictability of midpalatal suture separation with MARPE. Coordination between orthodontist and surgeon—informed by CBCT assessment—is no longer optional. It is essential for efficient, stable outcomes. Orthodontist Mark emphasizes that early communication and shared imaging allow both disciplines to optimize their respective biomechanics.
Skeletal vs. Dentoalveolar Loading:
The MARPE Advantage
in Orthognathic Cases
The fundamental difference between MARPE and traditional tooth-borne expansion lies in the anchor site. Conventional RPE and SARPE (surgically-assisted rapid maxillary expansion) apply force through the maxillary first molars and/or premolars. This dental anchorage produces inevitable buccal tipping and dentoalveolar protrusion, especially in patients with thin alveolar bone or high buccal cortical plate density. For a patient already requiring surgical correction of the transverse plane, this dentoalveolar side effect complicates the surgical plan and may necessitate broader osteotomy cuts or additional segment manipulation. MARPE, by contrast, anchors expansion forces directly to the midpalatal region via two miniscrews placed in the anterior or central palate. The BENEfit system and similar proprietary devices distribute load close to the midpalatal suture itself, redirecting force vectors toward the skeletal midline rather than laterally through tooth roots. Research indicates that this direct skeletal loading produces a higher frequency of true midpalatal suture separation and greater proportional increase in nasal width and maxillary basal width—the dimensions actually needed for skeletal correction. For the surgeon planning a Le Fort I osteotomy or maxillary advancement in a patient with transverse deficiency, a pre-expanded maxilla offers distinct advantages: the pyramid is already wider at the base, the dental midline and skeletal midline are better aligned, and the dentoalveolar side effects are minimized. Post-surgical relapse is also reduced when the maxilla has undergone true skeletal splitting rather than dentoalveolar tipping. In cases where the patient will eventually need bimaxillary surgery, pre-operative MARPE effectively reduces the magnitude of sagittal correction needed and improves surgical symmetry.
When to Expand First: The Case for
Pre-Surgical MARPE
In most clinical scenarios, particularly in skeletally mature or near-mature patients (age 14–25 with no active growth), MARPE should precede orthognathic surgery by 3 to 6 months. This sequencing offers several advantages. First, the expanding maxilla benefits from the lag phase of treatment—the 8 to 12 weeks of active activation followed by 6 months of retention with miniscrews in situ allows the suture to calcify progressively and resist relapse. The midpalatal suture separation achieved during MARPE is more durable than the osteotomized segments created during SARPE, which may attempt to close if the maxilla is then instrumented or moved during the same surgical episode. Second, pre-surgical MARPE allows the orthodontist to complete initial leveling and alignment before surgery. Many patients with severe transverse deficiency also present with crowding or crossbite, which compounds surgical planning. By widening the arch with MARPE and aligning the dentoalveolar structures first, you simplify the surgeon's task and reduce the complexity of the Le Fort I cuts. The surgeon can then focus purely on sagittal and vertical correction, knowing that transverse balance is already achieved. Third, imaging coordination becomes straightforward. A pre-treatment CBCT establishes the suture maturity and surgical anatomy. A second CBCT immediately after MARPE expansion (before retention begins) documents the degree of suture separation and maxillary width gain, allowing the surgeon to adjust osteotomy design accordingly. If the expansion achieved is 6–8 mm at the molar region, the surgeon can rely on this skeletal gain and adjust the sagittal Le Fort I advancement to avoid over-correction. A practical protocol: (1) Complete pre-expansion CBCT and surgical consultation; (2) Place MARPE miniscrews and activate 0.5 mm per day for 7–10 days, then 0.25 mm per day until target width is achieved (typically 7–10 mm inter-molar expansion); (3) Retain with miniscrews in place for minimum 6 months; (4) Obtain post-expansion CBCT 2–4 weeks before planned surgery; (5) Share imaging with surgeon; (6) Proceed to surgery.
Three Models: Expand First,
Surgery Second, or Concurrent
Coordination
Not all cases fit a single sequencing template. Three evidence-informed models apply to different patient presentations. Model 1: MARPE First (Recommended in Most Cases) Best for: Patients age 14–30, transverse deficiency ≥6 mm, moderate sagittal/vertical discrepancies, good suture maturity on CBCT. Sequence: MARPE activation and retention (6–8 months total), then 2–3 months of orthodontic alignment post-retention, then surgery. Timeline: 10–11 months total from start to surgery. Advantage: Maxilla is expanded and consolidated before surgical manipulation. Miniscrews can remain in situ for skeletal anchorage during final alignment if needed. Risk: Slight delay in overall treatment if surgery urgency exists. Patient compliance with long retention period is essential. Model 2: Surgery First (Limited Use) Best for: Patients with severe sagittal Class II or Class III with minimal transverse component, or when vertical correction and rotation are the surgical priorities. If MARPE is planned, it follows surgery by 6–12 weeks. Sequence: Comprehensive pre-surgical orthodontics, then surgery (Le Fort I ± mandibular correction), then MARPE placement and activation 6–12 weeks post-operatively. Timeline: 18–24 months total. Advantage: Addresses the primary skeletal problem first. Post-operative dentoalveolar orthodontics can be augmented with MARPE for final transverse refinement. Risk: The operated maxilla may resist MARPE expansion if osteotomy healing has already solidified. Achieving substantial additional width gain becomes difficult. Miniscrew placement in post-operated palate carries slightly higher infection risk. Model 3: Concurrent/Integrated (Advanced) Best for: Highly experienced teams with strong surgeon–orthodontist communication, moderate transverse deficiency, and complex asymmetries. MARPE is activated to 50–70% of final target, then surgery is planned. Post-operatively, MARPE activation resumes or is completed. Timeline: 12–15 months. Advantage: Reduces total treatment time. The surgeon benefits from partial skeletal expansion when planning osteotomy geometry. Risk: Higher complexity. Requires precise timing of surgical inputs. Miniscrews may require re-evaluation post-operatively for stability.
CBCT Assessment: Suture Maturity,
Bone Density, and Surgical Plan
Cone-beam computed tomography (CBCT) is mandatory when MARPE and orthognathic surgery are both being considered. Standard cephalometric radiographs and panoramic images are insufficient. They do not reveal suture calcification status, alveolar bone architecture, or asymmetric palatal anatomy that may influence miniscrew placement or expansion response. Key CBCT findings to evaluate: Midpalatal Suture Maturity: Five-stage classification systems (Haas, Fishman) assess whether the suture remains patent and capable of orthopedic response. In skeletally mature patients (age 20+), the suture often shows advanced calcification (stages 3–5), which may reduce MARPE expansion response and increase the risk that surgical (SARPE) assistance will eventually be needed. CBCT permits visualization of the exact degree of ossification—critical for informed patient counseling. A patient with stage 4 suture calcification should be informed that MARPE may yield 5–6 mm expansion rather than 8–10 mm, and that orthognathic surgery may still be necessary to achieve the full transverse correction. Alveolar and Palatal Bone Density: MARPE success depends not only on suture patency but also on bone quality. Patients with thin palatal vault, low bone density, or high palatal vault may experience miniscrew failure or inadequate force transmission. CBCT densitometry (when available) or visual assessment of cancellous bone can inform activation velocity. Dense bone may require slower activation (0.25 mm every other day) and longer retention. Thin bone may permit faster expansion but demands conservative loading. Asymmetry and Anatomy: Transverse deficiency is rarely symmetric. CBCT reveals whether the narrowing is isolated to the molar region or affects the entire maxilla, and whether there is associated asymmetry or cant. This information guides miniscrew placement (two anterior, two posterior, or offset positions) and helps predict whether expansion alone will correct the asymmetry or whether surgery will still be needed. Pterygomaxillary Junction and Tuberosity: If the surgeon is considering Le Fort I or segmental maxillary procedures, the pterygomaxillary relationship and maxillary tuberosity morphology are critical. MARPE applied to a maxilla with thick pterygomaxillary attachments may distribute expansion unevenly, and the surgeon must anticipate this during osteotomy design.
Step-by-Step: MARPE Activation,
Retention, and Surgical Handoff
Once you and the surgeon have agreed on pre-surgical MARPE sequencing, follow this clinical protocol to ensure optimal expansion and reliable surgical planning. Phase 1: Pre-MARPE Assessment and Planning (Weeks 1–2) Obtain pre-treatment CBCT focused on suture maturity, palatal vault anatomy, and miniscrew trajectory. Review surgical imaging with your surgical partner to confirm target expansion width and anticipated Le Fort I geometry. Conduct informed consent discussion addressing expansion timeline (8–10 weeks active, 6 months retention), miniscrew care, activation protocol, and retention phase requirements. Establish contact frequency: in-person check-ups every 2 weeks during active expansion and monthly during retention. Phase 2: Miniscrew Placement (Week 3) Place two miniscrews in the anterior palate (between lateral incisors and canines, at the midline, approximately 8 mm from the palatal vault floor) or use the hybrid approach with anterior and posterior screws depending on suture anatomy and expansion device (BENEfit system, MSE, or equivalent proprietary system). Verify miniscrew stability with percussion. Inadequate primary stability contraindicates MARPE. Start with a 1-week lag period (minimal activation) to establish osseointegration. Phase 3: Activation Protocol (Weeks 4–10) Standard activation: 0.5 mm per day (two quarter-turns on the expansion screw) for the first 2 weeks, then 0.25 mm per day (one quarter-turn) thereafter until target expansion is achieved. Monitor for diastema formation between maxillary central incisors—a clinical sign of active suture separation. Patient follows home care protocol: gentle saline rinse, miniscrew cleaning with soft-bristle toothbrush, avoidance of hard foods. Recheck every 2 weeks. If miniscrews loosen, assess bone integration and consider re-tightening or replacement. If expansion is asymmetric (one side expanding faster), adjust activation to balance force. Total expansion target: 7–10 mm at the molar region, depending on surgical requirements (confirm with surgeon). Phase 4: Retention (Weeks 11–26) Leave miniscrews in situ with minimal or no additional activation. This 6-month retention phase allows the midpalatal suture to re-calcify and consolidate, dramatically improving stability. Patient attends monthly appointments to check miniscrew security and palatal hygiene. Begin initial orthodontic leveling and alignment (wire changes, bracket elastics) during retention if timing permits—this does not interfere with expansion stability. Phase 5: Post-Expansion Imaging and Surgical Handoff (Week 24–26) Obtain post-expansion CBCT 2–4 weeks before planned surgery. Digitally compare pre- and post-CBCT to measure actual expansion, document suture separation, and confirm symmetric widening. Share imaging with surgeon along with a summary note documenting activation protocol, final width gain, and miniscrew status. Physician-to-physician communication at this point prevents surgical surprises. Confirm that Le Fort I osteotomy design accounts for the expansion already achieved. Phase 6: Miniscrew Removal and Surgical Clearance (Week 27) Remove miniscrews 1–2 weeks before surgery to allow soft tissue healing and eliminate miniscrew-related bleeding during the surgical field. Obtain intraoral photograph for surgical record. Provide the surgeon with current orthodontic status, miniscrew removal documentation, and any palatal scarring notes. Clear the patient for surgery.
Sequencing Errors: When MARPE and
Orthognathic Planning
Misalign
Several common mistakes erode treatment predictability and extend overall care time. Pitfall 1: Insufficient Suture Maturity Assessment Failure to obtain pre-treatment CBCT and properly stage the midpalatal suture leads to unrealistic expansion expectations. A patient with a Stage 4 or 5 fused suture may achieve only 4–5 mm expansion with MARPE despite 10+ weeks of activation. This suboptimal result then forces a difficult choice: continue with inadequate width and modify surgical plan, or refer for SARPE (adding surgical cost and time). Solution: Always assess suture maturity on CBCT before proposing MARPE to a patient already committed to surgery. If suture maturity is high and expansion is essential, discuss SARPE as the primary option rather than MARPE as a fallback. Pitfall 2: Inadequate Surgeon Coordination Orthodontists sometimes complete MARPE and expansion sequencing without confirming with the surgeon that the width gain is clinically useful or achievable. The surgeon may have designed the surgical plan assuming no expansion, or may have different goals for transverse correction. Result: Post-operative relapse, inadequate symmetry, or need for re-operation. Solution: Share pre-operative and post-expansion CBCT with the surgeon before your final retention phase. Attend a joint planning meeting (in person or by video) to review target expansion width and confirm that the surgeon's osteotomy geometry accounts for the expanded maxilla. Pitfall 3: Premature Miniscrew Removal Removing miniscrews and dismissing the patient for retention with appliances alone (brackets and archwires) significantly increases relapse risk. The miniscrews serve not only as expansion anchors but as retention anchors during the critical 6-month consolidation phase. Removing them before suture re-calcification is complete allows the maxilla to contract. Solution: Plan miniscrew removal no earlier than 6 months post-expansion, and preferably 1–2 weeks before surgery (allowing soft tissue healing but maintaining maximal retention benefit). Pitfall 4: Asymmetric Expansion Unaddressed If one miniscrew fails, becomes loose, or the patient activates the screw unevenly, expansion may proceed asymmetrically. A patient may end up with 8 mm expansion on the right side and 5 mm on the left—incompatible with a symmetric Le Fort I osteotomy. The surgeon either must accept asymmetry (increasing relapse risk and post-operative esthetics issues) or compensate with asymmetric osteotomy cuts (increasing complexity). Solution: Recheck patient every 2 weeks during activation. Educate patient on proper screw-turning technique (quarter-turns with controlled speed). Confirm miniscrew stability with percussion. Measure width clinically and radiographically to detect asymmetry early. Re-balance activation if asymmetry emerges. Pitfall 5: Insufficient Patient Education on Retention Compliance Patients often view the active expansion phase as the “treatment” and become impatient during retention. They may request miniscrew removal or fail to attend retention appointments. Incomplete retention then leads to partial relapse, reducing the surgical benefit and requiring last-minute treatment plan modifications. Solution: At MARPE initiation, explicitly explain that retention is as critical as activation—use analogies (“like letting concrete cure after pouring”). Establish a retention appointment schedule upfront. Offer reminders 2 weeks before each appointment. Discuss relapse risk at every visit. Involve parents (if minor) in compliance discussions.
Two Models: Pre-Surgical Expansion
and Surgical Integration
Case 1: Adolescent Class II with Transverse Deficiency—MARPE First Model Patient: 16-year-old female, dentoalveolar Class II division 1, maxillary width 32 mm (target 38 mm), no growth remaining (hand/wrist radiograph confirms, post-peak height velocity), planned for future maxillary advancement + mandibular setback. Pre-treatment CBCT: Midpalatal suture Stage 2–3 (patent, partially calcified), alveolar bone density normal, no asymmetry, adequate palatal vault height for miniscrew placement. Plan: MARPE (7–8 week activation, 6-month retention), then comprehensive orthodontics (3 months), then bimaxillary surgery (age 17–18, growth confirmation at re-evaluation). Sequence Timeline: Months 1–2, MARPE placement and initial activation. Months 2–3, continued activation + initial leveling. Months 3–9, retention with ongoing alignment. Month 9, post-expansion CBCT and surgical consultation. Months 10–12, pre-surgical final alignment. Month 12–13, surgery. Outcome: 7.5 mm inter-molar expansion achieved. Diastema of 2–3 mm appeared between central incisors (confirming suture separation). Post-expansion CBCT showed clean midpalatal split at multiple levels. Surgeon confirmed Le Fort I advancement could be reduced 2 mm sagittally due to transverse gain, reducing overall surgical complexity and relapse risk. Patient erupted second molars during treatment. They were included in final archwire during pre-surgical phase. Final surgical result: Class I molars, canines, and incisors. Excellent symmetry. Stable at 2-year follow-up. Case 2: Adult Severe Class III with Transverse and Vertical Deficiency—Concurrent Model (Advanced) Patient: 24-year-old male, skeletal Class III (SNB 83°, ANB −4°), anterior open bite 3 mm, maxillary width 34 mm, mandibular width 112 mm (true bimaxillary discrepancy), CBCT shows Stage 3 midpalatal suture (moderately fused), and planned for bimaxillary surgery with possible genioplasty. Plan: Given the surgical complexity and modest suture patency, a concurrent model was chosen. MARPE activated to 50% target (3–4 mm) over 4 weeks, then held. Surgery planned 2 weeks after activation halted. Post-operatively (6 weeks), MARPE re-activated to final 7 mm target over 4 additional weeks, then retained 6 months before final orthodontic alignment and fixed appliance removal. Sequence Timeline: Months 1–1.5, MARPE placement and partial activation. Week 6, Le Fort I + bilateral sagittal split osteotomy + genioplasty. Weeks 12–16 post-op, MARPE re-activation to final target. Months 6–12 post-op, retention and final alignment. Month 12, miniscrew removal and fixed appliance removal. Outcome: 7 mm final inter-molar expansion. Le Fort I mobility was enhanced by partial pre-operative expansion. Bilateral sagittal split osteotomy designs were optimized with awareness of anticipated post-operative transverse gain. Final anterior open bite closed via vertical correction and pre-surgical orthodontics. Patient achieved stable Class I occlusion. MARPE miniscrews remained integrated throughout surgery (palate was not osteotomized in this case, only the maxilla anteriorly), enabling reliable post-operative re-activation. Post-operative relapse minimal at 2-year follow-up.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
Should MARPE always precede orthognathic surgery?
In most cases, yes. Pre-surgical MARPE maximizes skeletal expansion response and simplifies the surgeon's osteotomy design. Exception: if suture maturity is high (Stage 4–5 ossification), SARPE may be more effective than MARPE alone, and the sequencing may be surgery-first or concurrent.
How long should retention occur before orthognathic surgery?
Minimum 6 months with miniscrews in situ. This allows the midpalatal suture to re-calcify and consolidate. Remove miniscrews 1–2 weeks before surgery for soft tissue healing. Premature removal or abbreviated retention increases relapse risk.
What CBCT findings contraindicate pre-surgical MARPE?
Stage 4–5 midpalatal suture fusion, inadequate palatal vault height for miniscrew placement, severe palatal anatomy variation, or thin alveolar bone density. In these cases, discuss SARPE as the expansion method or limit expansion targets.
Can miniscrews remain in place during Le Fort I osteotomy?
If miniscrews are in the central/anterior palate and the Le Fort I does not osteotomize the palate, miniscrews typically remain stable. Confirm with your surgeon. If osteotomy includes the hard palate, remove miniscrews 1–2 weeks pre-operatively.
How much inter-molar expansion is sufficient for surgical planning?
Typically 6–8 mm is clinically meaningful. This reduces sagittal Le Fort I advancement by 2–3 mm and improves transverse symmetry. Confirm specific target width with your surgeon before MARPE initiation based on surgical plan.
What does asymmetric MARPE expansion mean for the surgeon?
Asymmetric expansion (>2 mm difference side-to-side) may require the surgeon to adjust osteotomy cuts or offset vectors to maintain symmetry. Detect and correct asymmetry during active MARPE phase by rebalancing activation and monitoring every 2 weeks.
Can MARPE be done after orthognathic surgery?
Yes, if the surgical maxilla has healed (6–12 weeks post-op). Response is typically reduced because the already-operated maxilla resists orthopedic loading. Use only if transverse correction is insufficient post-operatively. Discuss relapse risk and modest expected gain.
What activation protocol minimizes relapse during MARPE retention?
Activate 0.5 mm/day for 2 weeks, then 0.25 mm/day until target. Leave miniscrews untouched during 6-month retention. If over-expanded (rare), deactivate minimally. Do NOT remove miniscrews early or reduce activation before 6 months. Relapse risk increases sharply.
How does midpalatal suture maturity stage influence MARPE timing?
Stage 1–2 (pre-pubertal/early pubertal): strong orthopedic response, 9–12 mm expansion possible. Stage 3 (adolescent/young adult): moderate response, 7–8 mm typical. Stage 4–5 (adult): minimal response, 4–6 mm or SARPE needed. Stage assessment guides patient counseling and method selection.
Should I obtain a second CBCT after MARPE expansion for surgical planning?
Yes. Post-expansion CBCT (2–4 weeks before surgery) documents actual width gain, suture separation pattern, and miniscrew status. Share this with the surgeon to confirm Le Fort I geometry accounts for the skeletal expansion already achieved and to finalize bony anatomy for surgery.
The decision to sequence MARPE before, during, or after orthognathic surgery depends on individual anatomy, surgical magnitude, and orthodontic goals. In most skeletally mature patients, expansion first maximizes skeletal response and simplifies the surgical plan. Close collaboration with your surgical team—sharing 3D imaging, establishing activation protocols, and timing retention phases—ensures seamless integration of both modalities. For case reviews and detailed treatment planning protocols, visit Orthodontist Mark's consultation resources or enroll in the advanced skeletal expansion course to master these complex sequencing scenarios.
